Martinu, T., Gowdy, K. M., Nugent, J. L., Kinnier, C. V., Kelly, F. L., Hollingsworth, J. W., & Palmer, S. M. (2011). Inhaled Lipopolysaccharide Enhances Alloimmune Lung Disease Via The TLR4-TRIF Pathway. In AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (Vol. 183). AMER THORACIC SOC.

Martinu, T., K. M. Gowdy, J. L. Nugent, C. V. Kinnier, F. L. Kelly, J. W. Hollingsworth, and S. M. Palmer. “Inhaled Lipopolysaccharide Enhances Alloimmune Lung Disease Via The TLR4-TRIF Pathway.” In AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol. 183. AMER THORACIC SOC, 2011.

Martinu T, Gowdy KM, Nugent JL, Kinnier CV, Kelly FL, Hollingsworth JW, et al. Inhaled Lipopolysaccharide Enhances Alloimmune Lung Disease Via The TLR4-TRIF Pathway. In: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. AMER THORACIC SOC; 2011.

Martinu, T., et al. “Inhaled Lipopolysaccharide Enhances Alloimmune Lung Disease Via The TLR4-TRIF Pathway.” AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, vol. 183, AMER THORACIC SOC, 2011.

Martinu T, Gowdy KM, Nugent JL, Kinnier CV, Kelly FL, Hollingsworth JW, Palmer SM. Inhaled Lipopolysaccharide Enhances Alloimmune Lung Disease Via The TLR4-TRIF Pathway. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. AMER THORACIC SOC; 2011.